18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort Trial.

Saved in:
Bibliographic Details
Title: 18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort Trial.
Authors: van Geel JJL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Province Groningen, The Netherlands., Eisses B; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Province Groningen, The Netherlands., Elias SG; Department of Epidemiology and Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Province Utrecht, The Netherlands., Brouwers AH; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Bensch F; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Province Groningen, The Netherlands., Gerritse SL; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Angus L; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Glaudemans AWJM; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Kuip EJM; Department of Medical Oncology, Radboud Medical Center, Nijmegen, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Vugts DJ; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Emmering J; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Maasstad Hospital, Rotterdam, The Netherlands., Arens AIJ; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Oyen WJG; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Radiology and Nuclear Medicine, Rijnstate, Arnhem, The Netherlands.; Department of Biomedical Sciences, Humanitas University and Department of Nuclear Medicine, Humanitas Clinical and Research Center, Milan, Italy., van der Vegt B; Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Lub-de Hooge MN; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands., Menke-van der Houven van Oord CW; Department of Medical Oncology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Province Groningen, The Netherlands., Schröder CP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Province Groningen, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Amsterdam, The Netherlands.
Corporate Authors: IMPACT-Metastatic Breast Cancer Consortium
Source: JAMA oncology [JAMA Oncol] 2026 Jun 01; Vol. 12 (6), pp. 611-618.
Publication Type: Journal Article; Multicenter Study; Clinical Trial
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2374-2445
DOI:10.1001/jamaoncol.2026.0767